CDTTW stock

Conduit Pharmaceuticals Inc. (CDTTW) financials

Lician Pro · $19.99/mo or $149/yrCompare AAPL vs MSFT

Conduit Pharmaceuticals Inc. income statement, balance sheet, and cash flow from the statement cache. Years sit on this URL — not a year mill.

Cached annual income statement
LineFY2025FY2024
Operating Income-$36.8M-$15.4M
Net Income-$39.2M-$17.8M
EPS (Diluted)-$1177.89-$20.53
Cached annual balance sheet
LineFY2025FY2024
Total Assets$5.65M$4.19M
Current Assets$4.38M$2.71M
Cash & Equivalents$1.51M$554.0K
PP&E$269.0K$40.0K
Total Liabilities$12.8M$11.0M
Current Liabilities$12.8M$10.7M
Shareholders' Equity-$7.17M-$6.79M
Retained Earnings-$68.3M-$29.1M
Cached annual cash flow
LineFY2025FY2024
Operating Cash Flow-$15.6M-$9.68M
CapExN/A$51.0K
Investing Cash Flow-$808.0K-$43.0K
Financing Cash Flow$17.4M$6.07M
Net Change in Cash$955.0K-$3.67M
Free Cash FlowN/A-$9.73M
These statements as JSON? API free 100/day

FAQ

What is CDTTW revenue?

CDTTW income-statement cache has no revenue figure yet.

Is CDTTW profitable?

Conduit Pharmaceuticals Inc. last cached net income is -$39.2M (FY2025).

What are CDTTW total assets?

Conduit Pharmaceuticals Inc. last cached total assets are $5.65M (FY2025).

What is CDTTW free cash flow?

No cached cash-flow row for CDTTW yet.

Not investment advice. Cached statements, not a live tape.